Consensus statement for the diagnosis, treatment, and prognosis of kaposiform hemangioendothelioma
- PMID: 39831682
- DOI: 10.1002/ijc.35344
Consensus statement for the diagnosis, treatment, and prognosis of kaposiform hemangioendothelioma
Abstract
Kaposiform hemangioendothelioma (KHE) is a rare vascular tumor that typically presents in infancy or early childhood. As awareness of KHE increases, it is imperative that the management of KHE be updated to reflect the latest evidence-based guidelines. The aim of this study was to integrate the literature and Chinese expert opinions to provide updated recommendations that will guide the diagnosis, treatment, and prognosis of patients with KHE. According to this consensus statement, 28 nationally peer-recognized experts in vascular anomalies and an expert in evidence-based medicine were assembled and formed three consensus subgroups. A series of key themes and questions were developed for each group, including recommendations for diagnosis, treatment, and prognosis. A systematic search was conducted for English-language articles published in PubMed and other relevant studies identified by the expert panel. A diagnosis of KHE necessitates the integration of clinical, imaging, and histologic features. The treatment of KHE should be tailored to the specific characteristics of each patient, including the size of the lesion, the presence of symptoms, the location, and the overall condition of the patient. In addition to focusing on the disease itself, it is also important to consider the complications of KHE and their impact on prognosis. The recommendations presented herein are intended to assist in the guidance of clinical practice and decision-making in patients with KHE, with the objective of improving patient outcomes.
Keywords: consensus statement; diagnosis; kaposiform hemangioendothelioma; prognosis; treatment.
© 2025 UICC.
References
REFERENCES
-
- Drolet BA, Trenor CC 3rd, Brandão LR, et al. Consensus‐derived practice standards plan for complicated Kaposiform hemangioendothelioma. J Pediatr. 2013;163(1):285‐291.
-
- Croteau SE, Liang MG, Kozakewich HP, et al. Kaposiform hemangioendothelioma: atypical features and risks of Kasabach‐Merritt phenomenon in 107 referrals. J Pediatr. 2013;162(1):142‐147.
-
- Lim YH, Bacchiocchi A, Qiu J, et al. GNA14 somatic mutation causes congenital and sporadic vascular tumors by MAPK activation. Am J Hum Genet. 2016;99(2):443‐450.
-
- Carli D, Kalantari S, Manicone R, et al. Kaposiform hemangioendothelioma further broadens the phenotype of PIK3CA‐related overgrowth spectrum. Clin Genet. 2021;100(5):624‐627.
-
- Dadras SS, Skrzypek A, Nguyen L, et al. Prox‐1 promotes invasion of kaposiform hemangioendotheliomas. J Invest Dermatol. 2008;128(12):2798‐2806.
Publication types
MeSH terms
Supplementary concepts
Grants and funding
- ZYJC21060/1·3·5 Project for Disciplines of Excellence-Clinical Research Interdisciplinary Innovation Project of West China Hospital of Sichuan University
- 25NSFJQ0140/Excellent Youth Foundation of Sichuan Province of China
- YGJC004/Med-X Center for Informatics Funding Project
- 2020HXFH048/1·3·5 Project for Disciplines of Excellence-Clinical Research Incubation Project of West China Hospital of Sichuan University
- 2023HXFH004/1·3·5 Project for Disciplines of Excellence-Clinical Research Incubation Project of West China Hospital of Sichuan University
- 2022NSFSC1480/Key Project in the Science & Technology Program of Sichuan Province
- 2022YFS0225/Key Project in the Science & Technology Program of Sichuan Province
- 2022YFS0233/Key Project in the Science & Technology Program of Sichuan Province
- 2022SCUH0033/Project of '0 to 1' of Sichuan University
- 82273556/National Natural Science Foundation of China
- 82473553/National Natural Science Foundation of China
LinkOut - more resources
Full Text Sources
Medical
Research Materials